Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2002 1
2003 2
2004 1
2005 1
2007 1
2008 5
2009 4
2010 3
2013 4
2014 5
2015 11
2016 10
2017 5
2018 3
2019 1
2020 4
2021 6
2022 6
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Results by year

Filters applied: . Clear all
Page 1
Current Medical Therapy for Adenomyosis: From Bench to Bedside.
Etrusco A, Barra F, Chiantera V, Ferrero S, Bogliolo S, Evangelisti G, Oral E, Pastore M, Izzotti A, Venezia R, Ceccaroni M, Laganà AS. Etrusco A, et al. Among authors: bogliolo s. Drugs. 2023 Nov;83(17):1595-1611. doi: 10.1007/s40265-023-01957-7. Epub 2023 Oct 14. Drugs. 2023. PMID: 37837497 Free PMC article. Review.
The role of fulvestrant in endometrial cancer.
Bogliolo S, Cassani C, Dominoni M, Orlandini A, Ferrero S, Iacobone AD, Viazzo F, Venturini PL, Spinillo A, Gardella B. Bogliolo S, et al. Expert Opin Drug Metab Toxicol. 2017 May;13(5):537-544. doi: 10.1080/17425255.2016.1244264. Epub 2016 Oct 19. Expert Opin Drug Metab Toxicol. 2017. PMID: 27696906 Review.
A review of phase II and III drugs for the treatment and management of endometriosis.
Perrone U, Evangelisti G, Laganà AS, Bogliolo S, Ceccaroni M, Izzotti A, Gustavino C, Ferrero S, Barra F. Perrone U, et al. Among authors: bogliolo s. Expert Opin Emerg Drugs. 2023 Dec;28(4):333-351. doi: 10.1080/14728214.2023.2296080. Epub 2023 Dec 26. Expert Opin Emerg Drugs. 2023. PMID: 38099328 Review.
Veliparib for the treatment of ovarian cancer.
Bogliolo S, Cassani C, Dominoni M, Musacchi V, Venturini PL, Spinillo A, Ferrero S, Gardella B. Bogliolo S, et al. Expert Opin Investig Drugs. 2016;25(3):367-74. doi: 10.1517/13543784.2016.1146677. Epub 2016 Feb 16. Expert Opin Investig Drugs. 2016. PMID: 26807493 Review.
Oxaliplatin for the treatment of ovarian cancer.
Bogliolo S, Cassani C, Gardella B, Musacchi V, Babilonti L, Venturini PL, Ferrero S, Spinillo A. Bogliolo S, et al. Expert Opin Investig Drugs. 2015;24(9):1275-86. doi: 10.1517/13543784.2015.1062874. Epub 2015 Jun 30. Expert Opin Investig Drugs. 2015. PMID: 26125301 Review.
Advances in pharmacotherapy for treating endometriosis.
Tafi E, Leone Roberti Maggiore U, Alessandri F, Bogliolo S, Gardella B, Vellone VG, Grillo F, Mastracci L, Ferrero S. Tafi E, et al. Among authors: bogliolo s. Expert Opin Pharmacother. 2015;16(16):2465-83. doi: 10.1517/14656566.2015.1085510. Epub 2015 Sep 7. Expert Opin Pharmacother. 2015. PMID: 26569155 Review.
Pharmacokinetic considerations for therapies used to treat interstitial cystitis.
Gardella B, Porru D, Allegri M, Bogliolo S, Iacobone AD, Minella C, Nappi RE, Ferrero S, Spinillo A. Gardella B, et al. Among authors: bogliolo s. Expert Opin Drug Metab Toxicol. 2014 May;10(5):673-84. doi: 10.1517/17425255.2014.896338. Epub 2014 Mar 12. Expert Opin Drug Metab Toxicol. 2014. PMID: 24621003 Review.
70 results